Multiple Sclerosis News Today Forums › Forums › Treating MS › Alternative Treatments › Temelimab Reduces Brain Atrophy in Patients with RRMS

  • Alternative Treatments

    Temelimab Reduces Brain Atrophy in Patients with RRMS

    Posted by MS News Today Moderator on April 2, 2019 at 10:48 am

    Two-year treatment with temelimab reduced brain atrophy, or shrinkage, preserved myelin, and reduced disease progression in patients with relapsing-remitting multiple sclerosis (RRMS), according to findings from an extension study of a Phase 2b clinical trial. Click here to learn more about this trial and its findings.

    Are you interested in more news about this treatment for RRMS?

    replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .